Metera Pharmaceuticals Inc.
- UEI
- NUVXLC5FAYJ3
- CAGE
- 88MV5
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Website
- meterarx.com
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Inhaled IRK inhibitors as a novel therapeutic for IPF | National Heart Lung and Blood Institute (NIH) | $1,515,600 |
Quick answers
Is Metera Pharmaceuticals Inc. registered in SAM.gov?
Metera Pharmaceuticals Inc.'s SAM.gov registration expired on December 23, 2020.
What is Metera Pharmaceuticals Inc.'s most recent federal award?
Metera Pharmaceuticals Inc.'s most recent federal grant award is Inhaled IRK inhibitors as a novel therapeutic for IPF (R44HL151067), from National Heart Lung and Blood Institute (NIH), on February 10, 2020.
On GovTribe
See Metera Pharmaceuticals Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors